The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
The Colorado Thyroid Disease Prevalence Study
Abstract
CONTEXT: The prevalence of abnormal thyroid function in the United States and the significance of thyroid dysfunction remain controversial. Systemic effects of abnormal thyroid function have not been fully delineated, particularly in cases of mild thyroid failure. Also, the relationship between traditional hypothyroid symptoms and biochemical thyroid function is unclear. OBJECTIVE: To determine the prevalence of abnormal thyroid function and the relationship between (1) abnormal thyroid function and lipid levels and (2) abnormal thyroid function and symptoms using modern and sensitive thyroid tests. DESIGN: Cross-sectional study. PARTICIPANTS: Participants in a statewide health fair in Colorado, 1995 (N = 25 862). MAIN OUTCOME MEASURES: Serum thyrotropin (thyroid-stimulating hormone [TSH]) and total thyroxine (T4) concentrations, serum lipid levels, and responses to a hypothyroid symptoms questionnaire. RESULTS: The prevalence of elevated TSH levels (normal range, 0.3-5.1 mIU/L) in this population was 9.5%, and the prevalence of decreased TSH levels was 2.2%. Forty percent of patients taking thyroid medications had abnormal TSH levels. Lipid levels increased in a graded fashion as thyroid function declined. Also, the mean total cholesterol and low-density lipoprotein cholesterol levels of subjects with TSH values between 5.1 and 10 mIU/L were significantly greater than the corresponding mean lipid levels in euthyroid subjects. Symptoms were reported more often in hypothyroid vs euthyroid individuals, but individual symptom sensitivities were low. CONCLUSIONS: The prevalence of abnormal biochemical thyroid function reported here is substantial and confirms previous reports in smaller populations. Among patients taking thyroid medication, only 60% were within the normal range of TSH. Modest elevations of TSH corresponded to changes in lipid levels that may affect cardiovascular health. Individual symptoms were not very sensitive, but patients who report multiple thyroid symptoms warrant serum thyroid testing. These results confirm that thyroid dysfunction is common, may often go undetected, and may be associated with adverse health outcomes that can be avoided by serum TSH measurement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, 25-40% of patients on long-term levothyroxine treatment have a TSH concentration below or above the reference range.7,9,10”
From Hypothyroidism (2024) · cites this paper as [10]
In the citing paper
“The prevalence of hypothyroidism (subclinical and overt) ranges from 0•2% to 5•3% in Europe 3, 35- 37 and 0•3% to 3•7% in the USA, 10 depending on the definition used and the population.”
From Hypothyroidism (2024) · cites this paper as [10]
In the citing paper
“Approximately 10-15% of patients express dissatisfaction on levothyroxine despite TSH normalisation, due to persistent, residual symptoms that might reflect ongoing hypothyroidism.10,11”
From Hypothyroidism (2024) · cites this paper as [10]
In the citing paper
“60% of unselected euthyroid individuals have one or more symptom that may be attributable to hypothyroidism. 39”
From Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement (2023) · cites this paper as [39]
In the citing paper
“Patientsaged 70 years or older may have fewer symptoms or signs and are less likely to exhibit someclassicsignssuchascoldintoleranceandweight gain compared with younger individuals (aged ≤ 55 years). 41”
From Hypothyroidism: A Review (2025) · cites this paper as [41]
In the citing paper
“The lack of specificity of hypothyroid symptoms and signs (49) and, particularly in case of autoimmune thyroid disease (AITD), the slow development of the pathologic state, renders difficult the assessment of the adequacy of the replacement therapy on a purely clinical basis.”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [49]
In the citing paper
“There is some evidence that patients who report more symptoms and more recently developed symptoms are more likely to have hypothyroidism.10”
From Hypothyroidism (2024) · cites this paper as [10]
In the citing paper
“symptoms consistent with the presence of hypothyroidism are nonspecific and cannot be reliably used to differentiate those with hypothyroidism from euthyroid people. 39 -41”
From Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement (2023) · cites this paper as [39]
In the citing paper
“Common symptoms include fatigue (74%-86%), weight gain (24%59%), cold intolerance (35%-65%), bradycardia (12%-19%), constipation(33%-41%),andcognitiveimpairment(45%-48%),includingmemorylossanddifficultyconcentrating. 41,42”
From Hypothyroidism: A Review (2025) · cites this paper as [41]
In the citing paper
“Common symptoms include fatigue (74%-86%), weight gain (24%59%), cold intolerance (35%-65%), bradycardia (12%-19%), constipation(33%-41%),andcognitiveimpairment(45%-48%),includingmemorylossanddifficultyconcentrating. 41,42”
From Hypothyroidism: A Review (2025) · cites this paper as [41]
In the citing paper
“Common symptoms include fatigue (74%-86%), weight gain (24%59%), cold intolerance (35%-65%), bradycardia (12%-19%), constipation(33%-41%),andcognitiveimpairment(45%-48%),includingmemorylossanddifficultyconcentrating. 41,42”
From Hypothyroidism: A Review (2025) · cites this paper as [41]
In the citing paper
“Common symptoms include fatigue (74%-86%), weight gain (24%59%), cold intolerance (35%-65%), bradycardia (12%-19%), constipation(33%-41%),andcognitiveimpairment(45%-48%),includingmemorylossanddifficultyconcentrating. 41,42”
From Hypothyroidism: A Review (2025) · cites this paper as [41]
In the citing paper
“Common symptoms include fatigue (74%-86%), weight gain (24%59%), cold intolerance (35%-65%), bradycardia (12%-19%), constipation(33%-41%),andcognitiveimpairment(45%-48%),includingmemorylossanddifficultyconcentrating. 41,42”
From Hypothyroidism: A Review (2025) · cites this paper as [41]
In the citing paper
“Common symptoms include fatigue (74%-86%), weight gain (24%59%), cold intolerance (35%-65%), bradycardia (12%-19%), constipation(33%-41%),andcognitiveimpairment(45%-48%),includingmemorylossanddifficultyconcentrating. 41,42”
From Hypothyroidism: A Review (2025) · cites this paper as [41]
In the citing paper
“In this respect it is noteworthy that hypothyroid symptoms were reported, despite a normal serum TSH, by 12.1% of 22,842 participants (1,525 of which were taking thyroid medication) in the Colorado Thyroid Disease Prevalence Study [17] .”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [17]
In the citing paper
“Despite this, studies show that for many people levothyroxine dosage is not adjusted as they age because either monitoring for thyroid dysfunction may be not be carried out or indicated dose adjustments identified by monitoring may not be implemented.9 10 11 12 13 14”
From Levothyroxine dose and risk of fractures in older adults: nested case-control study (2011) · cites this paper as [11]
In the citing paper
“Our study specifically focused on older adults, who have a higher baseline risk of fracture15 26 56 and are more vulnerable to excessive levothyroxine replacement.11 12 13 14”
From Levothyroxine dose and risk of fractures in older adults: nested case-control study (2011) · cites this paper as [11]
In the citing paper
“Hypothyroidism is mainly induced by autoimmune thyroid diseases and thyroidectomy (1, 2).”
From Levothyroxine: conventional and novel drug delivery formulations. (2023) · cites this paper as [2]
In the citing paper
“Even though its prevalence has not been precisely documented, non-optimal thyroxine therapy, as evidenced by TSH levels above (or below) the reference range, is common (Table 2)”
From Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report (2017) · cites this paper as [13]
In the citing paper
“The prevalence of hypothyroidism increases with age and subclinical hypothyroidism affects up to 15% of adults 65 years of age or older, when non-age-specific TSH reference ranges are used (9, 12–14).”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [9]
In the citing paper
“Hypothyroid symptoms are non-specific and vary among patients, especially in the setting of subclinical hypothyroidism. The same symptoms are also quite common in euthyroid individuals and thus often overlap with the symptoms developed in patients with hypothyroidism (9).”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [9]
In the citing paper
“Five to 24 percent of all patients taking L-T4 develop iatrogenic thyrotoxicosis (9, 11, 78, 81–83), a proportion that is even higher in the elderly [up to 41% (79)].”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [9]
In the citing paper
“It is recognized that up to one-quarter of the healthy normal population may have 'hypothyroid' symptoms such as lethargy and weight gain.14”
From Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee (2016) · cites this paper as [14]
In the citing paper
“Hypothyroidism is associated with a small but significant increase in lipid parameters (31), in particular, an elevation of low-density lipoproteins (LDLs) (32).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [31]
In the citing paper
“Overt hypothyroidism is diagnosed when serum TSH is elevated and circulating THs are low and is prevalent in 0.2% to 2% of nonpregnant adults (31,37).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [31]
In the citing paper
“The stated prevalence of SCH in published reports ranges from 4% to 10% of the adult population, being more common in women and older individuals (31,37).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [31]
In the citing paper
“most (at least 80%) patients with hypothyroidism have SCH (31).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [31]
Citations
Cites
THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY
Tunbridge, W. M. G., Evered, D. C., Hall, R., Appleton, D. R., BREWIS, M., CLARK, F., Evans, J. G., Young, E. T., Bird, T., & Smith, P. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb01340.x · Cited by 2,665
Ingbar, S. H. (1965) · Archives of Internal Medicine · doi:10.1001/archinte.1965.03870060154035 · Cited by 1,745
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259
SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN
Martin, M., Browner, W. S., Hulley, S. B., Kuller, L., & Wentworth, D. N. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90597-0 · Cited by 1,117
Fade, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01739.x · Cited by 567
Sawin, C. T. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.145.8.1386 · Cited by 439
L-Thyroxine Therapy in Subclinical Hypothyroidism: A Double-Blind, Placebo-Controlled Trial
COOPER, D. S., HALPERN, R., WOOD, L. C., LEVIN, A. A., & RIDGWAY, E. C. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-18 · Cited by 423
Self-citationZulewski, H., Müller, B., Exer, P., Miserez, A. R., & Staub, J.-J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3810 · Cited by 391
Applications of a New Chemiluminometric Thyrotropin Assay to Subnormal Measurement*
SPENCER, C. A., LoPRESTI, J. S., PATEL, A., GUTTLER, R. B., EIGEN, A., SHEN, D., GRAY, D., & NICOLOFF, J. T. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-2-453 · Cited by 371
Staub, J.-J., Althaus, B., Engler, H., Ryff, A., Trabucco, P., Marquardt, K., BURCKHARDT, D., Girard, J., & Weintraub, B. D. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90782-7 · Cited by 317
Cited by
Sorted by citations
Items 601–700 of 1,011
The Management of Thyroid Nodules
Wienhold, R., Scholz, M. R., Adler, J., Günster, C., & Paschke, R. (2013) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2013.0827 · Cited by 45
Subclinical hypothyroidism and vascular risk: An update
Lioudaki, E., Mavroeidi, N., Mikhailidis, D. P., & Ganotakis, E. S. (2013) · HORMONES · doi:10.14310/horm.2002.1437 · Cited by 45
Ünal, E., Akın, A., Yıldırım, R., Demir, V., Yıldız, İ., & Haspolat, Y. K. (2016) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.3719 · Cited by 45
Kanyılmaz, G., Aktan, M., Koç, M., Demir, H., & Demir, L. S. (2017) · Medical dosimetry · doi:10.1016/j.meddos.2017.03.003 · Cited by 45
Thyroid disease in the perimenopause and postmenopause period
Uygur, M. M., Yoldemir, T., & Yavuz, D. G. (2018) · Climacteric · doi:10.1080/13697137.2018.1514004 · Cited by 45
Levothyroxine Formulations: Pharmacological and Clinical Implications of Generic Substitution
Benvenga, S., & Carlé, A. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01079-1 · Cited by 46
Prevalence, risks, and comorbidity of thyroid dysfunction: a cross-sectional epidemiological study
Rashad, N. M., & Samir, G. M. (2019) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_22_19 · Cited by 45
Razvi, S., McMillan, C., & Weaver, J. U. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02381.x · Cited by 46
Robinson, A., Crane, L. A., Davidson, A. J., & Steiner, J. F. (2002) · Preventive Medicine · doi:10.1006/pmed.2001.0950 · Cited by 45
Palacios, S. S., Brugos‐Larumbe, A., Guillén‐Grima, F., & Galofré, J. C. (2013) · Clinical Endocrinology · doi:10.1111/cen.12216 · Cited by 45
The Management of Subclinical Hyperthyroidism by Thyroid Specialists
McDermott, M. T., Woodmansee, W. W., Haugen, B. R., Smart, A., & Ridgway, E. C. (2003) · Thyroid · doi:10.1089/10507250360731532 · Cited by 45
Self-citationThe Genetic Basis of Thyroid Function: Novel Findings and New Approaches
Kuś, A., Chaker, L., Teumer, A., Peeters, R. P., & Medici, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz225 · Cited by 44
Biondi, B., Bartalena, L., Chiovato, L., Lenzi, A., Mariotti, S., Pacini, F., Pontecorvi, A., Vitti, P., & Trimarchi, F. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0511-z · Cited by 44
Cardiovascular risk in elderly hypothyroid patients
Mariotti, S., & Cambuli, V. M. (2007) · Thyroid · doi:10.1089/thy.2007.0130 · Cited by 44
Update on subclinical thyroid dysfunction
Hashimoto, K. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej22-0182 · Cited by 44
Korevaar, T. I. M., Leung, A. M., Alexander, E. K., Bliddal, S., Boelaert, K., Brenta, G., Chou, R., Dhillon‐Smith, R. K., Dosiou, C., Eaton, J. L., et al. (2026) · Thyroid · doi:10.1177/10507256261445624 · Cited by 47
Update on subclinical hyperthyroidism.
Donangelo, I., & Braunstein, G. D. (2011) · PubMed · Cited by 44
Aghili, R., Khamseh, M. E., Malek, M., Hadian, A., Baradaran, H. R., Najafi, L., & Emami, Z. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.32423 · Cited by 44
Headache Disorders May Be a Risk Factor for the Development of New Onset Hypothyroidism
Martin, A. T., Pinney, S. M., Xie, C., Herrick, R. L., Bai, Y., Buckholz, J. M., & Martin, V. T. (2016) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12943 · Cited by 45
Long-term Methimazole Therapy in Juvenile Graves’ Disease: A Randomized Trial
Azizi, F., Takyar, M., Madreseh, E., & Amouzegar, A. (2019) · PEDIATRICS · doi:10.1542/peds.2018-3034 · Cited by 44
The impact of thyroid diseases starting from birth on reproductive function
Krassas, G. E., & Markou, K. B. (2019) · HORMONES · doi:10.1007/s42000-019-00156-y · Cited by 44
Đula, I. S. Đ. S., Pleić, N., Leko, M. B., Gunjača, I., Torlak, V., Brdar, D., Punda, A., Polašek, O., Hayward, C., & Zemunik, T. (2022) · Biology · doi:10.3390/biology11030394 · Cited by 44
Hamano, K., & Inoue, M. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.95 · Cited by 44
A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020
Rizza, R. A., Vigersky, R. A., Rodbard, H. W., Ladenson, P. W., Young, W. F., Surks, M. I., Kahn, R., & Hogan, P. F. (2003) · Endocrine Practice · doi:10.4158/ep.9.3.210 · Cited by 44
Health status in patients with sub-clinical hypothyroidism
Razvi, S., Ingoe, L. E., McMillan, C., & Weaver, J. U. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01907 · Cited by 45
Metabolic cardiovascular disease risk factors and their clustering in subclinical hypothyroidism
Ashizawa, K., Imaizumi, M., Usa, T., Tominaga, T., Sera, N., Hida, A., Ejima, E., Neriishi, K., Soda, M., Ichimaru, S., et al. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03697.x · Cited by 44
Cebeci, E., Alıbaz-Öner, F., Usta, M., Yurdakul, S., & Ergüney, M. (2012) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31823581dd · Cited by 44
Guarding our Nation's Thyroid Health
Dunn, J. T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8346 · Cited by 45
Cappelli, C., Castello, R., Marini, F., Paoletta, A., Marchetti, M., Saullo, M., Cristiano, A., Pirola, I., Gandossi, E., Ferlin, A., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00699 · Cited by 43
Rajendra, K. C., Khatiwada, S., Mehta, K. D., Pandey, P., Lamsal, M., & Majhi, S. (2015) · Journal of Thyroid Research · doi:10.1155/2015/305241 · Cited by 43
Low awareness and under-diagnosis of hypothyroidism
Gottwald‐Hostalek, U., & Schulte, B. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1997258 · Cited by 43
Reversible Cognitive, Motor, and Driving Impairments in Severe Hypothyroidism
Smith, C. D., Grondin, R., LeMaster, W., Martin, B., Gold, B. T., & Ain, K. B. (2014) · Thyroid · doi:10.1089/thy.2014.0371 · Cited by 43
Prevalence of unknown thyroid disorders in a Sardinian cohort
Delitala, A., Pilia, M. G., Ferreli, L., Loi, F., Curreli, N., Balaci, L., Schlessinger, D., & Cucca, F. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0182 · Cited by 43
Gu, L., Yang, J., Gong, Y., Ma, Y., Yan, S., Huang, Y., Wang, Y., & Peng, Y. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13118 · Cited by 43
Reuters, V. S., Almeida, C. D. P., Teixeira, P. D. F. D. S., Vigário, P. D. S., Ferreira, M. M., de Castro, C. L. N., Brasil, M. A. A., Costa, A. J. L., Buescu, A., & Vaisman, M. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000200006 · Cited by 43
Subclinical Hypothyroidism and Risk for Incident Myocardial Infarction Among Postmenopausal Women
LeGrys, V. A., Funk, M. J., Lorenz, C., Giri, A., Jackson, R. D., Manson, J. E., Schectman, R., Edwards, T. L., HEISS, G. M., & Hartmann, K. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4065 · Cited by 43
Vigário, P. D. S., de Oliveira Chachamovitz, D. S., Cordeiro, M. F. N., dos Santos Teixeira, P. D. F., de Castro, C. L. N., de Oliveira, F. P., & Vaisman, M. (2011) · Thyroid® · doi:10.1089/thy.2010.0052 · Cited by 42
Combination L-T3 and L-T4 therapy for hypothyroidism
Wartofsky, L. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/01.med.0000432611.03732.49 · Cited by 42
Ross, D. S. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13410 · Cited by 42
Brain Fog in Hypothyroidism: Understanding the Patient’s Perspective
Ettleson, M. D., Raine, A., Batistuzzo, A., Batista, S. P., McAninch, E., Teixeira, M. C. T. V., Jonklaas, J., Laiteerapong, N., Ribeiro, M. O., & Bianco, A. C. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2021.12.003 · Cited by 42
Carrillo-Sepúlveda, M. A., Ceravolo, G. S., Fürstenau, C. R., Monteiro, P. D. S., Bruno-Fortes, Z., de Carvalho, M. H. C., Laurindo, F. R. M., Tostes, R. C., Webb, R. C., & Barreto‐Chaves, M. L. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061982 · Cited by 42
Marrie, R. A., Yu, B. N., Leung, S., Elliott, L. J., Warren, S., Wolfson, C. M., Tremlett, H. L., Fisk, J. D., & Blanchard, J. (2012) · Neuroepidemiology · doi:10.1159/000339757 · Cited by 42
Relationship between Diabetic Retinopathy and Subclinical Hypothyroidism: a meta-analysis
Wu, J., Yue, S., Geng, J., Liu, L., Teng, W., Liu, L., & Chen, L. (2015) · Scientific Reports · doi:10.1038/srep12212 · Cited by 43
Endocrine profile of the VCD-induced perimenopausal model rat
Carolino, R. O. G., Barros, P. T., Kalil, B., & Anselmo-Franci, J. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226874 · Cited by 42
Epidemiology of thyroid disorders in the Lifelines Cohort Study (the Netherlands)
Wouters, H. J. C. M., Slagter, S. N., Kobold, A. C. M., van der Klauw, M. M., & Wolffenbuttel, B. H. R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242795 · Cited by 42
Kawkgi, O. M. E., Ross, D. S., & Stan, M. N. (2020) · Clinical Endocrinology · doi:10.1111/cen.14374 · Cited by 46
Does a carpal tunnel syndrome predict an underlying disease?
de Rijk, M. C., Vermeij, F. H., Suntjens, M., & van Doorn, P. A. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.102145 · Cited by 42
Ye, Y., Xie, H., Zeng, Y., Zhao, X., Tian, Z., & Zhang, S. (2013) · Endocrine Practice · doi:10.4158/ep13237.or · Cited by 42
Thyroid function after hysterosalpingography using an oil-soluble iodinated contrast medium
Mekaru, K., 神山, 茂., Masamoto, H., Sakumoto, K., & Aoki, Y. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802246364 · Cited by 41
Iodine nutrition in Brazil: where do we stand?
Medeiros-Neto, G. A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000400014 · Cited by 41
Overprescribed Medications for US Adults: Four Major Examples
Safer, D. J. (2019) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3906 · Cited by 41
Thyroid hormones in male reproduction and infertility
Alahmar, A. T., Dutta, S., & Sengupta, P. (2019) · Asian Pacific Journal of Reproduction · doi:10.4103/2305-0500.268135 · Cited by 41
Life Without Thyroid Hormone Receptor
Shi, Y. (2021) · Endocrinology · doi:10.1210/endocr/bqab028 · Cited by 41
Silva, L. M., Chávez, J. H., Canalli, M. H. B. D. S., & Zanetti, C. R. (2003) · Hormone Research in Paediatrics · doi:10.1159/000069069 · Cited by 41
Wells, B. J., & Hueston, W. J. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02262.x · Cited by 41
Upper Limit of Normal Serum Thyroid-Stimulating Hormone: A Moving and Now an Aging Target?
Fatourechi, V. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2285 · Cited by 41
Jensen, E. A., Blaabjerg, O., Petersen, P. H., & Hegedűs, L. D. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.078964 · Cited by 41
Zhao, M., Yang, T., Chen, L., Tang, X., Guan, Q., Zhang, B., Zhang, X., Zhang, H., Wang, C., Xu, J., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0219 · Cited by 41
Prevalence of Clinical and Subclinical Thyroid Disease in a Peritoneal Dialysis Population
Ng, Y. Y., Wu, S., Lin, H. D., Hu, F. H., Hou, C. C., Chou, Y. Y., Chiu, S. M., Sun, Y. H., Cho, S. S.-Y., & Yang, W. C. (2011) · Peritoneal Dialysis International · doi:10.3747/pdi.2010.00202 · Cited by 41
Camargo, R. Y. A., Tomimori, E. K., Neves, S. C., Knobel, M., & Medeiros-Neto, G. A. (2006) · Clinics · doi:10.1590/s1807-59322006000400006 · Cited by 41
Identification of undiagnosed inflammatory arthritis in a community health fair screen
Deane, K. D., Striebich, C. C., Goldstein, B. L., Derber, L. A., Parish, M. C., Feser, M. L., Hamburger, E. M., Brake, S., Belz, C., Goddard, J., et al. (2009) · Arthritis Care & Research · doi:10.1002/art.24834 · Cited by 41
Shi, Y., Ritchie, J. W. A., & Taylor, P. M. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00219-x · Cited by 41
Syed, W., Samarkandi, O. A., Alsadoun, A. S., Harbi, M. K. A., & Al‐Rawi, M. B. A. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.912424 · Cited by 40
Wang, X., Zhen, W., Liu, Y., Wu, C., Jiang, J., Hashimoto, K., & Zhou, X. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106658 · Cited by 41
Sharma, R. B., Alegria, J. D., Talor, M. V., Rose, N. R., Caturegli, P., & Burek, C. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7740 · Cited by 40
Euthyroid Goiter With and Without Nodules
Führer, D., Bockisch, A., & Schmid, K. W. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0506 · Cited by 40
The secondary dyslipidemia and deranged serum phosphate concentration in thyroid disorders
Al-Tonsi, A. A., Abdel-Gayoum, A.-G. A., & Saad, M. G. (2004) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2003.10.006 · Cited by 40
Five-year Incidence and Progression of Thyroid Dysfunction in an Older Population
Gopinath, B., Wang, J. J., Kifley, A., Wall, J. R., Eastman, C. J., Leeder, S., & Mitchell, P. (2010) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2009.02156.x · Cited by 40
Lucas, A., Julián, M. T., Cantón, A., Castell, C., Casamitjana, R., Martínez-Cáceres, E. M., & Granada, M. L. (2010) · Endocrine · doi:10.1007/s12020-010-9397-2 · Cited by 40
Evaluation of autonomic activity in patients with subclinical hypothyroidism
Şahin, İ., Turan, N., Koşar, F., Taşkapan, Ç., & Günen, H. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345374 · Cited by 40
Cho, J., Kim, H. J., Lee, J. H., Park, I. R., Moon, J. S., Yoon, J. S., Lee, I., Won, K. C., & Lee, H. W. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.198 · Cited by 40
Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2019) · Drugs in Context · doi:10.7573/dic.212597 · Cited by 41
Sarlis, N. J., Gourgiotis, L., Pucino, F., & Tolis, G. (2002) · HORMONES · doi:10.14310/horm.2002.1152 · Cited by 40
Hypothyroidism After a Cancer Diagnosis: Etiology, Diagnosis, Complications, and Management
Carter, Y. M., Sippel, R. S., & Chen, H. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0237 · Cited by 43
Carbamazepine and risk of hypothyroidism: a prospective study
Simko, J., & Horáček, J. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00883.x · Cited by 40
Papi, G., Pearce, E. N., Braverman, L. E., Betterle, C., & Roti, E. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.01.004 · Cited by 39
Gluvic, Z. M., Obradovic, M. M., Stewart, A. J., Essack, M., Pitt, S. J., Samardzic, V. S., Šoškić, S., Gojobori, T., & Isenović, E. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.758043 · Cited by 42
Critically ill severe hypothyroidism: a retrospective multicenter cohort study
Bourcier, S., Coutrot, M., Ferré, A., Grunderbeeck, N. V., Charpentier, J., Hraiech, S., Azoulay, É., Nseir, S., Aïssaoui, N., Messika, J., et al. (2023) · Annals of Intensive Care · doi:10.1186/s13613-023-01112-1 · Cited by 39
Yu, Y.-T., Ho, C.-T., Hsu, H.-S., Li, C.-I., Davidson, L. E., Liu, C.-S., Li, T., Shih, C., Lin, C., & Lin, W. (2013) · Endocrine · doi:10.1007/s12020-013-9915-0 · Cited by 39
Mean platelet volume in patients with subclinical hypothyroidism
Yilmaz, H., Ertuğrul, Ö., Ertuğrul, B., & Ertuğrul, D. T. (2011) · Platelets · doi:10.3109/09537104.2010.508130 · Cited by 39
Outcome of in vitro fertilization in women with subclinical hypothyroidism
Cai, Y., Zhong, L., Guan, J., Guo, R., Niu, B., Ma, Y., & Su, H. (2017) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-017-0257-2 · Cited by 39
Barić, A., Brčić, L., Gračan, S., Škrabić, V., Brekalo, M., Šimunac, M., Lovrić, V. T., Anić, I., Barbalić, M., Zemunik, T., et al. (2018) · Immunological Investigations · doi:10.1080/08820139.2018.1529040 · Cited by 39
Alıbaz-Öner, F., Yurdakul, S., Öner, E., Üzüm, A. K., & Ergüney, M. (2011) · Endocrine · doi:10.1007/s12020-011-9465-2 · Cited by 39
Effects of thyroidectomy, T4, and DITPA replacement on brain blood vessel density in adult rats
Schlenker, E. H., Hora, M. J., Liu, Y., Redetzke, R. A., Morkin, E., & Gerdes, A. M. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00027.2008 · Cited by 39
Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia
Tagami, T., Kimura, H., Ohtani, S., Tanaka, T., Tanaka, T., Hata, S., Saito, M. H., Miyazaki, Y., Araki, R., Tanaka, M., et al. (2011) · Endocrine Journal · doi:10.1507/endocrj.k11e-012 · Cited by 39
Erden, G., Turhan, S., Sezer, S., Guctekin, A., Uçar, F., Giniş, Z., Öztürk, Ö., & Bingöl, S. (2008) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2008.96 · Cited by 39
Popławska‐Kita, A., Siewko, K., Telejko, B., Modzelewska, A., Myśliwiec, J., Milewski, R. J., Górska, M., & Szelachowska, M. (2013) · International Journal of Endocrinology · doi:10.1155/2013/981638 · Cited by 39
Serum creatine kinase and lactate dehydrogenase activities in patients with thyroid disorders
McGrowder, D., Fraser, Y., Gordon, L., Crawford, T., & Rawlins, J. (2011) · Nigerian Journal of Clinical Practice · doi:10.4103/1119-3077.91755 · Cited by 39
Kleinwechter, H. J. (2011) · Der Diabetologe · doi:10.1007/s11428-010-0672-x · Cited by 39
Endogenous and exogenous thyrotoxicosis and risk of incident cognitive disorders in older adults.
Adams, R., Oh, E. S., Yasar, S., Lyketsos, C. G., & Mammen, J. S. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.5619 · Cited by 38
The Effect of Famotidine, Esomeprazole, and Ezetimibe on Levothyroxine Absorption
Ananthakrishnan, S., Braverman, L. E., Levin, R. M., Magnani, B., & Pearce, E. N. (2008) · Thyroid · doi:10.1089/thy.2007.0381 · Cited by 38
Das, D., Banerjee, A., Jena, A. B., Duttaroy, A. K., & Pathak, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112613 · Cited by 43
Chen, G., Wu, J., Lin, Y.-H., Huang, B., Yao, J. Y., Jiang, Q., Wen, J., & Lin, L. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0710 · Cited by 38
Cabral, M. D., Teixeira, P., Soares, D. V., Leite, I. S., Salles, E. F., & Waisman, M. (2011) · Clinics · doi:10.1590/s1807-59322011000800003 · Cited by 38
Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer
Zheng, J., Li, C., Lu, W., Wang, C., & Ai, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.9201 · Cited by 38
Chandra, A. (2016) · Kidney Research and Clinical Practice · doi:10.1016/j.krcp.2016.06.003 · Cited by 38
Thyroid Hormone Regulation of Adult Neurogenesis
Fanibunda, S. E., Desouza, L. A., Kapoor, R., Vaidya, R. A., & Vaidya, V. A. (2017) · Vitamins and hormones · doi:10.1016/bs.vh.2017.04.006 · Cited by 40
Yao, K., Zhao, T., Zeng, L., Yang, J., Liu, Y., He, Q., & Zou, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-22897-3 · Cited by 38
Subclinical hypothyroidism: When to treat
Azim, S., & Nasr, C. E. (2019) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.86a.17053 · Cited by 39
Waliszewska‐Prosół, M., Bladowska, J., Budrewicz, S. P., Sąsiadek, M. J., Dziadkowiak, E., & Ejma, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-82281-6 · Cited by 38
Metadata
- Authors
- Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C.
- Affiliations
- University of Nebraska Medical Center (US)
- Abbott (United States) (US)
- University of Colorado Denver (US)
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2000-02-28
- Volume
- 160
- Issue
- 4
- Pages
- 526
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2140936682
- Cited by
- 2,824
- References
- 50
- Citations by year
- 2026: 49 · 2025: 64 · 2024: 86 · 2023: 138 · 2022: 158 · 2021: 151 · 2020: 191 · 2019: 147 · 2018: 148 · 2017: 166 · 2016: 161 · 2015: 140 · 2014: 144 · 2013: 147 · 2012: 132
- FWCI
- 31.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- thyroid dysfunction, hypothyroidism, thyroid-stimulating hormone, thyroxine, serum lipids, cholesterol, LDL cholesterol, thyroid medication, cardiovascular risk
- MeSH terms
- Adult, Age Factors, Aged, Colorado, Cross-Sectional Studies, Diagnosis, Differential, Female, Humans, Lipids, Male, Middle Aged, Surveys and Questionnaires, Sex Factors, Thyroid Diseases, Thyroid Hormones, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
